Cat Number: PIGD-0190

Sotalol HCl Tablet 160 mg 100/bottle

APIs
Synonyms
d, l- N-[4-[1-hydroxy-2-[(1-methylethyl) amino]ethyl]phenyl] methanesulfonamide monohydrochloride
Description
Sotalol hydrochloride tablets (AF) are indicated for the maintenance of normal sinus rhythm [delay in time to recurrence of atrial fibrillation/atrial flutter (AFIB/AFL)] in patients with symptomatic AFIB/AFL who are currently in sinus rhythm. Because sotalol hydrochloride tablets (AF) can cause life-threatening ventricular arrhythmias, it should be reserved for patients in whom AFIB/AFL is highly symptomatic. Patients with paroxysmal AFIB whose AFIB/AFL that is easily reversed (by Valsalva maneuver, for example) should usually not be given sotalol hydrochloride tablets (AF).

In general, antiarrhythmic therapy for AFIB/AFL aims to prolong the time in normal sinus rhythm. Recurrence is expected in some patients.

Sotalol hydrochloride tablets (AF) are also indicated for the treatment of documented life-threatening ventricular arrhythmias and is marketed under the brand name Betapace . Sotalol hydrochloride tablets, however, must not be substituted for sotalol hydrochloride tablets (AF) because of significant differences in labeling (i.e., patient package insert, dosing administration and safety information).
Molecular Weight
308.8
Molecular Formula
C12H20N2O3S•HCl
Appearance
white, crystalline solid
Brand Reference
Betapace Af
Strength
160 mg
NDC Number
42806-123-01
Size
100
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top